GEOVAX LABS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
GEOVAX LABS, INC. (GOVX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $1.30 million as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-09-17
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.30M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.20M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.37M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.62T.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $1.30M S-1 · filed 2026-09-17 |
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.37M S-1 · filed 2026-09-17 |
| 2025-09-30 | $1.62T 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.89T 10-Q · filed 2025-07-28 |
| 2025-03-31 | $2.20M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $515.97K 10-K · filed 2025-03-27 |
| 2024-09-30 | $655.31K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $342.16K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $451.02K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $554.59K 10-K · filed 2024-02-29 |
| 2023-09-30 | $738.28K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $962.09K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.45M 10-K · filed 2023-03-23 |
| 2022-09-30 | $849.57K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.04M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.23M 10-Q · filed 2022-04-27 |
| 2021-09-30 | $486.94K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $543.13K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $599.32K 10-Q · filed 2021-05-06 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |